Journal

The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R

Informations de publication

Date de publication:
10 07 2020
Historique:
received: 13 09 2019
revised: 06 05 2020
pubmed: 13 5 2020
medline: 14 1 2021
entrez: 13 5 2020
Statut: ppublish

Résumé

The oncogene RAS is one of the most widely studied proteins in cancer biology, and mutant active RAS is a driver in many types of solid tumors and hematological malignancies. Yet the biological effects of different

Identifiants

pubmed: 32393580
pii: S0021-9258(17)48957-5
doi: 10.1074/jbc.RA119.011080
pmc: PMC7363148
doi:

Substances chimiques

KRAS protein, human 0
MAS1 protein, human 0
Membrane Proteins 0
Proto-Oncogene Mas 0
raf Kinases EC 2.7.11.1
GTP Phosphohydrolases EC 3.6.1.-
NRAS protein, human EC 3.6.1.-
Proto-Oncogene Proteins p21(ras) EC 3.6.5.2

Banques de données

PDB
['6OB2', '1HE8', '4G0N', '3CON', '6MBT']

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

9335-9348

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR000114
Pays : United States
Organisme : NIH HHS
ID : S10 OD021527
Pays : United States
Organisme : NIGMS NIH HHS
ID : P30 GM124165
Pays : United States
Organisme : CCR NIH HHS
ID : HHSN261200800001C
Pays : United States
Organisme : NCI NIH HHS
ID : HHSN261200800001E
Pays : United States

Déclaration de conflit d'intérêts

Conflict of interest—The authors declare that they have no conflicts of interest with the contents of this article.

Références

Biochim Biophys Acta. 2007 Aug;1773(8):1177-95
pubmed: 17428555
Proc Natl Acad Sci U S A. 2019 Oct 29;116(44):22122-22131
pubmed: 31611389
Sci Rep. 2016 Jul 15;6:29765
pubmed: 27416752
Nat Protoc. 2015 Oct;10(10):1556-66
pubmed: 26379229
Nat Methods. 2016 Oct;13(10):849-51
pubmed: 27571549
Sci Rep. 2019 Jun 3;9(1):8239
pubmed: 31160609
Cancer Biol Ther. 2008 Apr;7(4):609-13
pubmed: 18614856
Nat Commun. 2016 Feb 08;7:10647
pubmed: 26854029
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
Nucleic Acids Res. 2011 Sep 1;39(17):e118
pubmed: 21727090
Sci Signal. 2013 Apr 02;6(269):pl1
pubmed: 23550210
Hum Mol Genet. 2011 Nov 1;20(21):4132-42
pubmed: 21828076
J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674
pubmed: 19461840
Sci Rep. 2019 Jul 19;9(1):10512
pubmed: 31324887
ACS Chem Biol. 2015 Aug 21;10(8):1797-804
pubmed: 26006698
Cell. 2000 Dec 8;103(6):931-43
pubmed: 11136978
Nucleic Acids Res. 2015 Jan;43(Database issue):D805-11
pubmed: 25355519
Anal Chem. 2020 Apr 7;92(7):4971-4979
pubmed: 32106676
Ann Transl Med. 2018 May;6(9):162
pubmed: 29911110
Oncotarget. 2016 Apr 19;7(16):22257-70
pubmed: 26989027
J Mol Biol. 2004 Nov 5;343(5):1391-408
pubmed: 15491620
Bioinformatics. 2013 Mar 1;29(5):647-8
pubmed: 23325621
Pol J Pathol. 2008;59(2):93-6
pubmed: 18669174
Nat Genet. 2017 Mar;49(3):358-366
pubmed: 28092682
Nature. 2014 Jan 23;505(7484):495-501
pubmed: 24390350
Methods Enzymol. 2006;407:9-22
pubmed: 16757310
Genes Cancer. 2011 Mar;2(3):216-31
pubmed: 21779495
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):133-44
pubmed: 20124693
Nucleic Acids Res. 2013 Jan;41(Database issue):D377-86
pubmed: 23193289
Front Genet. 2012 Mar 15;3:35
pubmed: 22435069
Cancer Biol Ther. 2009 May;8(10):907-16
pubmed: 19276661
PLoS One. 2013;8(3):e58731
pubmed: 23505554
Cancer Discov. 2012 May;2(5):401-4
pubmed: 22588877
Fly (Austin). 2012 Apr-Jun;6(2):80-92
pubmed: 22728672
Oncotarget. 2016 Nov 22;7(47):76920-76933
pubmed: 27764775
Cancer Res. 2017 Nov 1;77(21):e35-e38
pubmed: 29092935
J Mol Diagn. 2017 Jan;19(1):4-23
pubmed: 27993330
Biophys J. 2019 Mar 19;116(6):1049-1063
pubmed: 30846362
BMC Cancer. 2013 Apr 01;13:169
pubmed: 23548132
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):213-21
pubmed: 20124702
Methods Mol Biol. 2017;1586:65-82
pubmed: 28470599
Methods Mol Biol. 2014;1116:193-208
pubmed: 24395366
Nature. 2012 Jul 18;487(7407):330-7
pubmed: 22810696
Lancet Oncol. 2011 Jun;12(6):594-603
pubmed: 21163703
Methods Mol Biol. 2011;680:3-28
pubmed: 21153370
Oncol Rep. 2017 Jul;38(1):283-292
pubmed: 28534981
Genome Med. 2015 Dec 07;7:127
pubmed: 26643039
Eur J Cancer. 2004 Dec;40(18):2717-25
pubmed: 15571953
Biotechnol J. 2008 Mar;3(3):311-24
pubmed: 18228541
Nucleic Acids Res. 2009 Jul;37(Web Server issue):W305-11
pubmed: 19465376

Auteurs

Andrew C Nelson (AC)

Department of Laboratory Medicine & Pathology, University of Minnesota, Minneapolis, Minnesota, USA nels2055@umn.edu dhirendra.simanshu@nih.gov emil-lou@umn.edu.

Thomas J Turbyville (TJ)

NCI RAS Initiative, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland, USA.

Srisathiyanarayanan Dharmaiah (S)

NCI RAS Initiative, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland, USA.

Megan Rigby (M)

NCI RAS Initiative, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland, USA.

Rendong Yang (R)

The Hormel Institute, University of Minnesota, Austin, Minnesota, USA.

Ting-You Wang (TY)

The Hormel Institute, University of Minnesota, Austin, Minnesota, USA.

John Columbus (J)

NCI RAS Initiative, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland, USA.

Robert Stephens (R)

NCI RAS Initiative, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland, USA.

Troy Taylor (T)

NCI RAS Initiative, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland, USA.

Drew Sciacca (D)

Department of Laboratory Medicine & Pathology, University of Minnesota, Minneapolis, Minnesota, USA.

Getiria Onsongo (G)

Department of Laboratory Medicine & Pathology, University of Minnesota, Minneapolis, Minnesota, USA.

Anne Sarver (A)

Department of Surgery, University of Minnesota, Minneapolis, Minnesota, USA.

Subbaya Subramanian (S)

Department of Surgery, University of Minnesota, Minneapolis, Minnesota, USA.

Dwight V Nissley (DV)

NCI RAS Initiative, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland, USA.

Dhirendra K Simanshu (DK)

NCI RAS Initiative, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland, USA nels2055@umn.edu dhirendra.simanshu@nih.gov emil-lou@umn.edu.

Emil Lou (E)

Department of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, Minnesota, USA nels2055@umn.edu dhirendra.simanshu@nih.gov emil-lou@umn.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH